Northrop Grumman Corporation

Q2 FY26Aerospace and Defense

Northrop Grumman Corporation Q2 FY26 Results — Earnings Call Analysis

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹559

Market cap₹79.4K Cr

P/E17.5

Published29 May 2026

What the Q2 FY26 call signalled

2 of 4 strong

RevenueRank 4

MarginRank 3

CapexYes

Order bookYes

Not discussed on this call: fundraise.

The short version

- Mid-single-digit sales growth expected for the full year 2026, supported by a near-record $96 billion backlog providing over 2 years of sales coverage. - Mid-single-digit sales growth expected for 2026, with full-year sales guidance reaffirmed between $43.5 billion and $44 billion.

From Northrop Grumman Corporation's Q2 FY26 earnings-call transcript · updated 29 May 2026.

Revenue & Sales Performance

Rank 4

Mid-single-digit sales growth expected for the full year 2026, supported by a near-record $96 billion backlog providing over 2 years of sales coverage.
Multiple new bidding opportunities could drive higher sales growth beyond mid-single digits.
Accelerated ramp-up expected in missile components production, especially solid rocket motors, contingent on contract awards.
International sales pipeline growing, with long-term potential to become a key contributor, though international contracts typically have longer cycles.
Sentinel program projected to grow at low double digits in 2026, moving toward 10% of company revenue over time.
B-21 program nearing 10% of revenue, expected to exceed that in coming years with accelerated production.
Weapons business (including missile defense) nearing 10% of sales, anticipated to be one of the fastest-growing segments.
Overall, growth driven by strong demand across missile defense, munitions, B-21, and Sentinel programs, plus emerging international opportunities.

Profitability & Margins

Mid-single-digit sales growth expected for 2026, with full-year sales guidance reaffirmed between $43.5 billion and $44 billion. (Page 4)
Sentinel program expected to grow low double digits this year and aim toward 10% of total revenue over time. (Page 8)
B-21 program nearing 10% of revenue and expected to exceed 10% over the next several years with accelerated production. (Page 8)
Weapons business close to 10% of sales, anticipated to be one of the fastest-growing segments, driven by munitions and new programs. (Page 8)
Operating margin projected in the low to mid-11% range for 2026, with expected margin improvements through the year due to production timing and mix. (Page 4)
EPS for Q1 2026 was $6.14, up substantially from the prior year, driven by higher sales and operating income. (Page 4)
Free cash flow guidance maintained at $3.1 billion to $3.5 billion despite higher capital investments. (Page 4)
Future margin expansion is possible as programs mature and manufacturing capabilities improve, subject to competitive environment. (Page 9)

See what Northrop Grumman Corporation said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

$200 million CapEx planned for 2026 to support increased production capacity on the B-21 program.
Majority of capital expenditures for B-21 expected in 2027, 2028, and 2029, largely to be completed this decade.
Investment in modernizing solid rocket motor (SRM) and munition technologies totaling over $2 billion made in recent years, with further production expansion completing by 2027.
New production facilities for weapons business are modular and adaptable to flex with demand.
Company investing approximately $2.5 billion for B-21 production ramp-up, alongside customer funding from reconciliation package.
Opened a new facility specifically for accelerating radar production to meet program requirements, including tooling and workforce training completed.
CapEx investments aimed at scaling capacity to meet growing demand, supporting sales growth and long-term profitability.

Fundraising & Capital Structure

In Q1, the company repaid $527 million of fixed rate debt, ending the quarter with over $2 billion in cash on hand, indicating no immediate need for new debt financing.
Capital expenditures are planned to increase to $1.85 billion in 2026, primarily to support increased production capacity, especially for the B-21 program.
The company did not announce any new fundraising activities through debt or equity.
Free cash flow guidance for 2026 remains strong at $3.1 billion to $3.5 billion, with efforts underway to offset impacts from increased capital investments.
No mention was made of plans for issuing new equity or additional debt in the near future.
The company appears focused on funding growth internally through cash flow and managing existing capital allocations.

See what Northrop Grumman Corporation said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Yes

Northrop Grumman's backlog stands at approximately $96 billion, providing over 2 years of sales coverage.
The company continues to see strong bookings, reinforcing growth prospects into next year.
Reconciliation dollars from recent defense budgets are starting to flow into contracts in 2026.
There are numerous new bidding opportunities underway, including international and U.S. defense programs.
The company is working to convert a robust international pipeline into firm orders, though international contracts tend to have longer cycles.
The 2027 defense budget request of $1.5 trillion, including increased funding for key programs like B-21 and Sentinel, indicates sustained demand.
Long-term demand signals and structured production frameworks with the Department of Defense support continued backlog growth.
Awards such as Lot 4 LRIP for B-21 and MDA awards (e.g., GPI) add to confirmed orders, with some contract decisions expected in Q3 2026.

How does Northrop Grumman Corporation rank vs peers in Aerospace and Defense?

Pro feature

ThisNorthrop Grumman Corporation

Rev 4Mar 3

See where Northrop Grumman Corporation sits in Aerospace and DefenseSee which companies these are, and every other name in the sector.Open rankings

Others in Aerospace and Defense this season

Kratos Defense & Security Solutions, Inc. (Q2 FY26)
Kratos Defense & Security Solutions, Inc. Q2 FY26 quarterly results analysis. Hypersonics revenue expected to grow from $400 million in 2026 to $700 million in
Leonardo DRS, Inc. (Q2 FY26)
Leonardo DRS, Inc. Q2 FY26 quarterly results analysis. Revenue growth in 2026 is expected between 7% to 9% year-over-year. Market Cap $12,914, P/E 42.8. AI-powe
Huntington Ingalls Industries, Inc. (Q2 FY26)
Huntington Ingalls Industries, Inc. Q2 FY26 quarterly results analysis. Shipbuilding revenue expected to grow steadily; reported 17.6% increase in Q1 2026 vs. M
BWX Technologies, Inc. (Q2 FY26)
BWX Technologies, Inc. Q2 FY26 quarterly results analysis. BWXT expects overall 2026 revenue of at least $3.75 billion, up high teens compared to 2025. Market C

Compare:vs Lockheed Martin Corporation vs Howmet Aerospace Inc.vs General Dynamics Corporation

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Northrop Grumman Corporation Q2 FY26 results?

What is Northrop Grumman Corporation share price analysis?

Northrop Grumman Corporation currently shows a neutral. The stock trades at a P/E of 17.5 with a market cap of $79,438. Investors should review the full earnings analysis for detailed insights.

Is Northrop Grumman Corporation planning capital expenditure?

- $200 million CapEx planned for 2026 to support increased production capacity on the B-21 program.

Keep Northrop Grumman Corporation on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.